爱尔眼科(300015) - 2016 Q2 - 季度业绩预告

Financial Performance - The company's net profit attributable to shareholders is expected to be approximately between 262.68 million and 282.89 million yuan, representing a growth of 30% to 40% compared to the same period last year, which was 202.06 million yuan[3] - The increase in performance is attributed to the rising brand influence and expanding operational scale of the company, leading to improved operational efficiency and profitability[5] - The estimated impact of non-recurring gains and losses on net profit for the reporting period is around 4 million yuan[6]